Analytical Data
-
基因名
FNDC3B
- Application
-
别名
(Factor for adipocyte differentiation 104)(HCV NS5A-binding protein 37)
-
种属
Human
-
表达系统
Yeast
-
标签
C- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q53EP0
-
表达区间
278-570aa
-
分子量
34.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FNDC3B (fibronectin type III domain-containing protein 3B) is a protein that has gained attention in recent years due to its potential roles in various biological processes, including cellular signaling, development, and disease progression. The interest in FNDC3B is primarily sparked by its association with metabolic regulation and its involvement in the pathophysiology of several conditions, such as obesity and insulin resistance. As an emerging focus in biomedical research, FNDC3B is being explored for its function in adipogenesis and energy metabolism, where it may influence the differentiation of adipocytes and modulate lipid metabolism. Additionally, studies suggest that FNDC3B may play a role in the modulation of immune responses and inflammation, further broadening its relevance in chronic diseases. Given the increasing prevalence of metabolic disorders globally, understanding the molecular mechanisms underlying FNDC3B's function could unveil new therapeutic targets. Consequently, the recombination and characterization of FNDC3B protein not only contribute to elucidating its biological roles but also offer insights into its potential applications in clinical settings, particularly in the development of novel interventions for metabolic syndromes and other related diseases.
